Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
D R D E E P A K L A N G A D EM B B S M D P G D A S S ( A P P L I E D S T A T I S T I C S )
A S S O P R O F I N P H A R M A C O L O G Y
B V D U D C amp H N A V I M U M B A I
Research Methodology[Session ndash III]
Research Methods Biostatistics
16022015 1405Research Methodology DrDeepak Langade
1 Basics of Research Methodology
2 Study designs
3 Study documentation
4 Regulatory amp legal aspects of biomedical research
5 Introduction to Statistics amp Biostatistics
6 Sample size estimation for research
7 Hypothesis testing amp Applied Biostatistics
8 Presentation of data and reading the data
2
Schedule of Program
Essential Documents in Biomedical Research
Contents
16022015 1405Research Methodology DrDeepak Langade
4
Essential Documents
Documents before start of study
Documents during study
Documents after completion of study
Responsibilities of Investigator
Case Record Form (CRF)
Informed Consent Process
Essential Documents
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Research Methods Biostatistics
16022015 1405Research Methodology DrDeepak Langade
1 Basics of Research Methodology
2 Study designs
3 Study documentation
4 Regulatory amp legal aspects of biomedical research
5 Introduction to Statistics amp Biostatistics
6 Sample size estimation for research
7 Hypothesis testing amp Applied Biostatistics
8 Presentation of data and reading the data
2
Schedule of Program
Essential Documents in Biomedical Research
Contents
16022015 1405Research Methodology DrDeepak Langade
4
Essential Documents
Documents before start of study
Documents during study
Documents after completion of study
Responsibilities of Investigator
Case Record Form (CRF)
Informed Consent Process
Essential Documents
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents in Biomedical Research
Contents
16022015 1405Research Methodology DrDeepak Langade
4
Essential Documents
Documents before start of study
Documents during study
Documents after completion of study
Responsibilities of Investigator
Case Record Form (CRF)
Informed Consent Process
Essential Documents
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Contents
16022015 1405Research Methodology DrDeepak Langade
4
Essential Documents
Documents before start of study
Documents during study
Documents after completion of study
Responsibilities of Investigator
Case Record Form (CRF)
Informed Consent Process
Essential Documents
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
6
Essential
Absolutely necessary indispensable fundamental basic
or constituting the essence of a person or a thing
Document
A piece of written or printed matter that provides a record or evidence of eventsan agreement ownership identification (evidence to record)
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents
Research Methodology DrDeepak Langade
7
Definitions (ICH ndashGCP)
Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced
Definitions(INDIAN GCP)
The Documents that permit evaluation of a study and the quality of the data generated
16022015 1405
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
8
Role of Essential Documents
These documents serve to demonstrate the compliance of the investigator and research team with the standards of Good Clinical Practice and with all applicable regulatory requirements
Could be subjected to
Audit
Inspection
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Essential Documents
16022015 1405Research Methodology DrDeepak Langade
9
Before start of study
During study
After study completion
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents before start of the Study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
11
Documents
Research protocol with amendments
Protocol synopsis
CRF DCF
Investigator Brochure (IB)
Informed consent document (ICD)
Patient information sheet (PIS)
Informed consent form (ICF)
Any advertisements communication for patients public
Financial aspects of the study
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
12
Documents contdhellip
Agreements
Insurance
EC IRB approvals (favorable)
Composition of EC IRB
CV Biodata of Research team
Normal reference range of investigations
Medical Dental Laboratory Technical procedures
CTRI Registration
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents before start of studySection 82 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
13
Documents contdhellip
Sample labels for IP
Instructions for handling IPtools
IP (COA Batch no make mfg expiry)
Blinding procedures
Decoding procedures
Master randomization chart
Regulatory approvals
DCGI
DGFT
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents during the Study
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
15
Additional Documents
IB updates
Revisions of protocol or other documents
Updates to reference ranges tools procedures
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents during the studySection 83 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
16
Additional Documents contdhellip
Interim analysis
Subject screening amp enrollment log
Subject identification code
IP accountability
Signed amp dated ICD
Record of patient samplestissuesfluid etc
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents after completion of the Study
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
18
Additional Documents
IB updates
Relevant communication with other parties involved
Source documents
CRFs (completed signed amp dated)
Safety data (adverse events serious adverse events)
IP destruction
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Documents after study completionSection 84 ICH-GCP
16022015 1405Research Methodology DrDeepak Langade
19
Additional Documents
Completed subjects ID code list
Audit certificate
Treatment allocation amp decoding documentation
Final study report
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Investigator Responsibilities
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
Investigator Responsibilities
16022015 1405Research Methodology DrDeepak Langade
21
Investigator statement
Maintain study documents
Informed consent
Patients wellbeing amp safety
Communication with outside vendors agencies parties
T H A N K Y O U
Questions
T H A N K Y O U
Questions